🟢 Chimeric Therapeutics is trading 14.29% up today with no verified catalyst identified

Chimeric Therapeutics is trading at A$0.01 (+14.29%) with no verified catalyst identified.

• No verified September 9, 2026 company announcement was identified in the ASX announcements search.
• The latest reported clinical update remains the earlier decision to cease CHM CDH17 enrolment and dosing after a second dose-limiting toxicity; this does not establish a September 10 catalyst.
• Major indices were essentially unchanged, and the move’s cause remains unclear, potentially reflecting low-priced-stock volatility or trading activity.